BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14376394)

  • 1. Clinical studies on a vasopressor agent: metaraminol (aramine). I. Observations in normotensive subjects.
    WEIL MH; SPINK WW
    Am J Med Sci; 1955 Jun; 229(6):661-9. PubMed ID: 14376394
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical studies on a vasopressor agent: metaraminol (aramine). II. Observations on its use in the management of shock.
    WEIL MH
    Am J Med Sci; 1955 Oct; 230(4):357-69. PubMed ID: 13258566
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies on vasopressor agent: metaraminol (aramine). III. Observations on its oral use in the treatment of hypotension.
    WEIL MH
    Am J Med Sci; 1957 Apr; 233(4):367-74. PubMed ID: 13410911
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular function. V. The circulatory effects of aramine; mechanism of action of vasopressor drugs in cardiogenic shock.
    SARNOFF SJ; CASE RB; BERGLUND E; SARNOFF LC
    Circulation; 1954 Jul; 10(1):84-93. PubMed ID: 13172865
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of respiratory acidosis on ECG and pressor responses to epinephrine, norepinephrine and metaraminol.
    HOULE DB; WEIL MH; BROWN EB; CAMPBELL GS
    Proc Soc Exp Biol Med; 1957 Mar; 94(3):561-4. PubMed ID: 13408326
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aramine--sympathomimetic with vasopressor effect].
    Jaros Z; Kralové H
    Cas Lek Cesk; 1968 Oct; 107(42):1276-7. PubMed ID: 5681918
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of aramine as a pressor agent during spinal anesthesia.
    POE MF
    Anesthesiology; 1954 Sep; 15(5):547-50. PubMed ID: 13189164
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the cerebral hemodynamic response to aramine and norepinephrine in the normotensive and hypotensive subject.
    MOYER JH; MORRIS G; SNYDER H; SMITH CP
    Circulation; 1954 Aug; 10(2):265-70. PubMed ID: 13182760
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experiences with metaraminol as a vasopressor agent in spinal anesthesia.
    MUNCHOW OB; GRANATELLI AF; COLLINS VJ; ROVENSTINE EA
    Anesthesiology; 1960; 21():471-5. PubMed ID: 14425226
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of shock with sympathicomimetic drugs. Use of metaraminol and comparison with other vasopressor agents.
    MILLS LC; VOUDOUKIS IJ; MOYER JH; HEIDER C
    Arch Intern Med; 1960 Dec; 106():816-23. PubMed ID: 13770952
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemodynamic effects of vasopressor agent (metaraminol) on hypotension in dogs produced by endotoxin.
    HINSHAW LB; MACLEAN LD; SPINK WW; VISSCHER MB; WEIL MH
    Proc Soc Exp Biol Med; 1956 Jul; 92(3):610-2. PubMed ID: 13359481
    [No Abstract]   [Full Text] [Related]  

  • 12. Alterations in central blood volume and cardiac output induced by positive pressure breathing and counteracted by metaraminol (aramine).
    BRAUNWALD E; BINION JT; MORGAN WL; SARNOFF SJ
    Circ Res; 1957 Nov; 5(6):670-5. PubMed ID: 13473068
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vasopressor action of some adrenergic amines in animals in experimental cardiac arrest].
    Pietrobono P; Bragheri R; Berizzi GF
    Acta Anaesthesiol; 1968; 19():Suppl 9:65-72. PubMed ID: 5757555
    [No Abstract]   [Full Text] [Related]  

  • 14. Atropine prevents increases in brain blood flow during hypertension in newborn piglets.
    Brubakk AM; Bratlid D; Oh W; Yao AC; Stonestreet BS
    Pediatr Res; 1984 Nov; 18(11):1121-6. PubMed ID: 6514438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness.
    WEIL MH; HOULE DB; BROWN EB; CAMPBELL GS; HEATH C
    Calif Med; 1958 Jun; 88(6):437-40. PubMed ID: 13536861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HEMODYNAMIC EFFECTS OF PRESSOR AGENTS IN SEPTIC AND MYOCARDIAL INFARCTION SHOCK.
    SMULYAN H; CUDDY RP; EICH RH
    JAMA; 1964 Oct; 190():188-94. PubMed ID: 14246588
    [No Abstract]   [Full Text] [Related]  

  • 17. The cardiovascular and renal hemodynamic effects of aramine.
    LIVESAY WR; MOYER JH; CHAPMAN DW
    Am Heart J; 1954 May; 47(5):745-56. PubMed ID: 13148114
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of vasopressor agents to increase somatic blood flow.
    Skinner DB; Camp TF; Austen WG
    Arch Surg; 1967 May; 94(5):610-8. PubMed ID: 6025897
    [No Abstract]   [Full Text] [Related]  

  • 19. [Electrocardiographical, oscillographical, sphygmographical and blood-pressure changes during isopropyl chloride anesthesia].
    BERIO E; CALLIGARI G; BOSISIO P; FINCATO M
    Minerva Anestesiol; 1956 May; 22(5):177-82. PubMed ID: 13348128
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of subcutaneous adrenalin on blood pressure and on pulse].
    BUGAJSKI J
    Acta Physiol Pol; 1955; 6(3):257-60. PubMed ID: 13301822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.